GEL-one 30 MG/3 ML syringe 3ML
Ended Awarded
- Contract number
- SPE2DR26F33XE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,554
Award facts
- Contract value 100% obligated
- $10,554.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,554 delivery order to Amerisourcebergen Drug Corp on July 13, 2026, for Gel-One 30 mg/3 ml syringes with an ultimate completion date of August 3, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor and medical supplier to federal healthcare systems and the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F33XE?
SPE2DR26F33XE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 13, 2026.
How much is contract SPE2DR26F33XE worth?
The government has obligated $10,554 on SPE2DR26F33XE.
Is contract SPE2DR26F33XE an order under another contract?
Yes. SPE2DR26F33XE is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F33XE competed?
The extent of competition for SPE2DR26F33XE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award